Spitsin S - Search Results

1

The treatment of multiple sclerosis with inosine.

Markowitz CE, Spitsin S, Zimmerman V, Jacobs D, Udupa JK, Hooper DC, Koprowski H. Markowitz CE, et al. Among authors: spitsin s. J Altern Complement Med. 2009 Jun;15(6):619-25. doi: 10.1089/acm.2008.0513. J Altern Complement Med. 2009. PMID: 19425822 Free PMC article. Clinical Trial.

2

Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins.

Spitsin S, Hooper DC, Mikheeva T, Koprowski H. Spitsin S, et al. Mult Scler. 2001 Jun;7(3):165-6. doi: 10.1177/135245850100700305. Mult Scler. 2001. PMID: 11475439

3

Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease.

Spitsin S, Hooper DC, Leist T, Streletz LJ, Mikheeva T, Koprowskil H. Spitsin S, et al. Mult Scler. 2001 Oct;7(5):313-9. doi: 10.1177/135245850100700507. Mult Scler. 2001. PMID: 11724447 Clinical Trial.

4

Role of uric acid in multiple sclerosis.

Spitsin S, Koprowski H. Spitsin S, et al. Curr Top Microbiol Immunol. 2008;318:325-42. doi: 10.1007/978-3-540-73677-6_13. Curr Top Microbiol Immunol. 2008. PMID: 18219824 Review.

5

Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure.

Spitsin S, Markowitz CE, Zimmerman V, Koprowski H, Hooper DC. Spitsin S, et al. J Hum Hypertens. 2010 May;24(5):359-62. doi: 10.1038/jhh.2009.83. Epub 2009 Oct 29. J Hum Hypertens. 2010. PMID: 19865105 Clinical Trial.

6

Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.

Scott GS, Spitsin SV, Kean RB, Mikheeva T, Koprowski H, Hooper DC. Scott GS, et al. Among authors: spitsin sv. Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16303-8. doi: 10.1073/pnas.212645999. Epub 2002 Nov 25. Proc Natl Acad Sci U S A. 2002. PMID: 12451183 Free PMC article.

7

Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.

Spitsin S, Portocarrero C, Phares TW, Kean RB, Brimer CM, Koprowski H, Hooper DC. Spitsin S, et al. J Neuroimmunol. 2008 May 30;196(1-2):8-15. doi: 10.1016/j.jneuroim.2008.02.004. Epub 2008 Apr 11. J Neuroimmunol. 2008. PMID: 18406473 Free PMC article.

8

Role of uric acid in Alzheimer's disease.

Spitsin S, Koprowski H. Spitsin S, et al. J Alzheimers Dis. 2010;19(4):1337-8. doi: 10.3233/JAD-2010-1336. J Alzheimers Dis. 2010. PMID: 20061607 Review. No abstract available.

9

Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis.

Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski H. Hooper DC, et al. Among authors: spitsin s. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):675-80. doi: 10.1073/pnas.95.2.675. Proc Natl Acad Sci U S A. 1998. PMID: 9435251 Free PMC article.

10

Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.

Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV. Hooper DC, et al. Among authors: spitsin sv. FASEB J. 2000 Apr;14(5):691-8. doi: 10.1096/fasebj.14.5.691. FASEB J. 2000. PMID: 10744626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters